CN Stock MarketDetailed Quotes

300347 Hangzhou Tigermed Consulting

Watchlist

49.60
-1.04-2.05%

Market Closed Jan 21 15:00 CST

42.90BMarket Cap44.77P/E (TTM)

Hangzhou Tigermed Consulting Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hangzhou Tigermed Consulting Q4 2024 Estimates Date

Currency：HKDMar 28, 2025

	Estimate	YoY
Revenue	2.20B	+15.37%
EPS	0.65	+247.91%

Analyst Rating

Strong Buy

Jan 21, 2025

Hangzhou Tigermed Consulting Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 1.901B	--
--	2024/Q4	-- / 1.986B	--
--	2024/Q3	1.709B / 2.053B	--
--	2024/Q2	1.698B / 2.066B	--
--	2024/Q1	1.660B / 2.216B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 1.901B--

--2024/Q4-- / 1.986B--

--2024/Q31.709B / 2.053B--

--2024/Q21.698B / 2.066B--

--2024/Q11.660B / 2.216B--

Unlock Free Earnings Estimates

Open Account

Hangzhou Tigermed Consulting Earnings Reports

Tiger Pharmaceuticals: Report for the third quarter of 2024

Oct 29, 2024 12:00 ET

Tiger Pharmaceuticals: 2024 Semi-Annual Report Summary

Aug 28, 2024 12:00 ET

Tiger Pharmaceuticals: Semi-Annual Report 2024

Aug 28, 2024 12:00 ET

Hangzhou Tigermed Consulting: 2024 First Quarter Report

Apr 25, 2024 12:00 ET

Symbol Price % Chg

Anhui Bossco Environmental Protection Technology

300422

5.32 +20.09%

MH Robot & Automation

301199

35.99 +20.01%

Shanghai Hajime Advanced Material Technology

See the daily top gainer.

Analysis

Analyst Rating

Updated: Jan 21, 2025

Strong Buy

Strong Buy
78.26%
Buy
21.74%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

Shenzhen Stock Exchange

Intraday+0.28%